Consistent with the analysis above, ATRX mRNA expression (RPKM) was different in grade II-IV astrocytic tumors (Fig.2a; P<0.05) and decreased in As than in pGBMs and sGBM (Fig.2a; P<0.05, P<0.05, respectively). The gene discussed is ATRX; the disease is astrocytic tumor.